- The New Money
- Posts
- Eli Lilly Bets Billions On Psychedelics, Amazon's New Battery Partner, And Bigtime Backers For General Purpose Robots
Eli Lilly Bets Billions On Psychedelics, Amazon's New Battery Partner, And Bigtime Backers For General Purpose Robots
The markets and trends that matter, made simple. Discover what’s next.
Eli Lilly Is Acquiring AtaiBeckley For Psychedelic Drug Development
Eli Lilly (NYSE: LLY) has entered into a new deal to acquire psychedelic drug discovery company AtaiBeckley (NASDAQ: ATAI) for up to $3.8 billion. AtaiBeckley’s two lead psychedelic derived compounds BPL-003 and VLS-01 are both designed to be short acting psychedelics for treatment-resistant depression that complete the entire therapeutic process in roughly two hours, which is a significant difference compared to other psychedelic medicines which can take anywhere from six to twelve hours.
Electrovaya and Amazon Form New Deal For Lithium-Ion Batteries
Electrovaya (NASDAQ: ELVA) entered into a new commercial agreement with Amazon (NASDAQ: AMZN) to supply them their Infinity Battery Technology for Amazon to use in their material handling operations. Electrovaya’s Infinity Battery Technology is a proprietary lithium-ion battery platform that is capable of powering material handling equipment including forklifts and pallet jacks, and the company has publicly stated they plan to deploy the technology in both robotics and energy storage systems.
Walden Robotics Raises $300 Million For General Purpose Robots
Walden Robotics successfully raised $300 million in a seed financing round led by Toyota’s venture capital arm. Walden Robotics develops and manufactures general purpose robots that are capable of performing manual labour in industrial environments alongside of human beings. Nvidia (NASDAQ: NVDA), Boeing (NYSE: BA), Samsung and CoreWeave (NASDAQ: CRWV) also participated in Walden Robotics’ capital raise.
The New Money App Is Here
Discover markets, trends, and the world’s most exciting stocks easier than ever before with the newest version of The New Money App, now available in the App Store and Google Play.
The Sprint
Eos Energy (NASDAQ: EOSE) was awarded a new multi-million dollar deal from the United States Department of War to deploy their Z3 zinc-based long duration energy storage system as an initial prototype to support the Golden Dome.
Nebius (NASDAQ: NBIS) entered into a new deal for high performance computing with San Francisco, California based artificial intelligence startup Reflection AI for roughly $1 billion.
Constellation Energy’s (NASDAQ: CEG) venture capital arm made a strategic equity investment into small modular reactor development company Blue Energy.
RoboStrategy (NASDAQ: BOT) successfully raised $15.9 million in a new equity financing round, which included a $10 million investment from co-founder and CEO Andrew Kang.
Holtec, one of the largest vertically integrated nuclear technology providers in the world, officially filed a Form S-1 with the United States Securities Exchange and Commission to raise an IPO financing round and list on the Nasdaq.
Elon Musk personally acquired gas and diesel turbine mobile power company APR Energy according to new filings with the Federal Trade Commission.
LimX, a China based humanoid robotics startup, successfully raised approximately $200 million in a pre-IPO financing round valuing the company at $2.2 billion.
HydroGraph (CSE: HG) entered into a new 10 year deal with wholesale gas supplier Western International for acetylene supply which will be used to manufacture ultra-pure graphene.
The Markets This Week
+35.3% | AtaiBeckley
+32.1% | ProCap BTC
+26.0% | Lucid Motors
+25.4% | Opal Fuels
+24.8% | PayPal
+17.4% | Dave Inc.
+16.2% | Helus Pharma
+13.3% | Enhanced Group
+13.0% | Custom Health
+12.7% | GigaCloud Technology
Top Trends This Week
+5.2% | Christian Angermayer
+3.9% | Mike Novogratz
+2.6% | Dan Morehead
+1.4% | Carbon Credits
+0.9% | a16z
Trending Now
Looking to connect? Reach out and get in touch.
New here? Join our community of 100,000+ individuals interested in uncovering the world’s most exciting early stage companies.
Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.